Studies related to Depression and Rhodiola Rosea

Clinical Trial Of Rhodiola Rosea L. Extract SHR-5 In The Treatment Of Mild To Moderate Depression

Effect Decrease
Trial Design Double blind
Trial Length 1-6 months
Number of Subjects 89
Gender Both Genders
Age Range 18-29, 30-44, 45-64
Notes for this study:
42 days supplementation of 340-680mg rhodiola SHR-5 extract was able to significantly reduce the symptoms of depression in persons with diagnosed depression, with only partial dose dependence noted.

The degree of improvement ranged from 30-35% (HAMD rating scale) to 50% reduced symptoms (higher dose on BDI).